Clinical Trials Directory

Trials / Completed

CompletedNCT01157819

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro (0.3% Ciprofloxacin Otic Foam) Compared to Twice-Daily Dosing of Ciloxan (0.3% Ciprofloxacin Otic Solution) in Patients With Acute External Otitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Otic Pharma · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the Safety and Efficacy of Foam Otic Cipro (0.3% Ciprofloxacin Otic Foam), used once-daily for 7 days for the treatment of Acute Diffuse Otitis Externa, compared to commercial ear drops used twice daily for 7 days.

Detailed description

Acute otitis externa (AOE) is defined as a diffuse inflammation of the external ear canal, which may also involve the pinna and/or the tympanic membrane. AOE is one of the most common infections encountered by otolaryngologists, pediatricians and family physicians. Diagnosis of AOE requires rapid onset (generally within 48 hours) of symptoms and signs of ear canal inflammation which includes: A) otalgia (often severe), itching or fullness, sometimes accompanied by reduced hearing or jaw pain; B) tenderness of the tragus and/or pinna; and C) diffuse ear canal edema with or without erythema, sometimes accompanied by ear discharge.

Conditions

Interventions

TypeNameDescription
DRUG0.3% Ciprofloxacin Ear Drops4 gtt b.i.d. for 7 days.
DRUGFoamOtic Cipro0.3% Ciprofloxacin Otic Foam, 1 application, q.d. for 7 days

Timeline

Start date
2010-07-01
Primary completion
2010-11-01
Completion
2010-12-01
First posted
2010-07-07
Last updated
2011-03-15

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT01157819. Inclusion in this directory is not an endorsement.